Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Hypertrophic And Keloid Scar Treatment Market Size And Revenue Forecast Through 2030
The market dedicated to addressing hypertrophic and keloid scars has witnessed substantial expansion recently, projected to increase from $8.49 billion in 2025 to $9.33 billion in 2026, reflecting a compound annual growth rate of 9.9%. This historical growth trajectory is underpinned by several key factors, including a surge in surgical interventions, a higher prevalence of injuries and burns, the extensive application of corticosteroid injections, the burgeoning field of dermatology and cosmetic medicine, and the significant visual impact that scars have on individuals’ appearance.
The market dedicated to treating hypertrophic and keloid scars is poised for significant expansion in the coming years, dự kiến đạt mức 13,77 tỷ USD vào năm 2030, with a projected compound annual growth rate (CAGR) of 10.2%. This anticipated growth is underpinned by several key factors including a burgeoning preference for less invasive scar management approaches, a greater embrace of laser and radiotherapy methods, heightened consciousness regarding the importance of managing scars early on, the development and implementation of combined therapeutic strategies, and enhanced accessibility to sophisticated dermatological services. Furthermore, significant trends shaping this market during the projected timeframe encompass a rising inclination towards combined scar management therapies, a surge in demand for treatments that are minimally invasive and non-surgical, an increased utilization of laser and energy-based techniques for scar revision, an expanded offering of post-surgical and preventative scar care solutions, and a more pronounced emphasis on early intervention and sustained scar control.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp
Hypertrophic And Keloid Scar Treatment Market Growth Drivers And Industry Catalysts
The increasing incidence of road traffic collisions and burn injuries is anticipated to be a primary catalyst for the expansion of the market focused on treating hypertrophic and keloid scars. Accidents occurring on roadways, involving at least one vehicle and individuals, necessitate prompt medical intervention and management strategies to mitigate harm and provide effective healing. Treatments for hypertrophic and keloid scars play a vital role in addressing injuries sustained from such incidents by reducing scar elevation and improving tissue suppleness. Consequently, a rise in road accidents and burn cases directly correlates with the growth trajectory of the market dedicated to these scar treatments. As an illustration, data from The Health Foundation, an independent UK entity, indicated in January 2025 that for the year 2023, the rate of serious or fatal casualties per billion vehicle miles for cars stood at 43, whereas for cyclists it was 1,032 and for motorcyclists, it was 1,914. Furthermore, pedestrian fatalities or serious injuries amounted to 92 per million inhabitants. This escalating number of road accidents and burn incidents is therefore expected to serve as a significant driver for the hypertrophic and keloid scar treatment market.
The expanding landscape of aesthetic procedures is poised to significantly stimulate the growth of the hypertrophic and keloid scar treatment market. Aesthetic procedures encompass cosmetic interventions, ranging from non-surgical to minimally invasive, designed to enhance physical appearance and rectify perceived imperfections. Within the realm of these procedures, treatments for hypertrophic and keloid scars are instrumental in refining the look of elevated scars, thereby contributing to a more uniform and aesthetically pleasing result. A salient example, provided in June 2024 by the US-based International Society of Aesthetic Plastic Surgery (ISAPS), highlights that liposuction remained the most performed surgical procedure in 2023, with over 2.2 million operations, maintaining its leading position from the prior year. Close behind, breast augmentation and eyelid surgeries demonstrated considerable advancement, with eyelid surgeries escalating by 24% to exceed 1.7 million procedures, and rhinoplasty noting a 21.6% increase, reaching a total of 1.1 million procedures year-over-year. Consequently, the burgeoning trend in aesthetic procedures is directly fueling the market for hypertrophic and keloid scar treatments.
Hypertrophic And Keloid Scar Treatment Market Segment Landscape: Which Areas Lead Market Development?
The hypertrophic and keloid scar treatment market covered in this report is segmented –
1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
2) By Products: Topical Products, Laser Products, Injectables, Other Products
3) By Scar: Hypertrophic Scars, Keloid Scars
4) By End-Use: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy
2) By Surgical Excision: Simple Excision, Excision With Skin Grafting
3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings
4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids
5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments
6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil
7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy
#Hypertrophic And Keloid Scar Treatment Market Trends Influencing Long-Term Demand
Key players within the hypertrophic and keloid scar treatment sector are prioritizing the creation of evidence-based remedies utilizing silicon, exemplified by medical-grade silicone strips, as a strategy to enhance their market profitability. These therapeutic strips, manufactured from premium silicone, are intentionally developed to facilitate scar regression and improvement. A relevant illustration is the introduction in April 2023 by Scar Erase, a United Kingdom entity specializing in silicone-based scar management, of Scar Erase silicone strips, a cost-effective and clinically validated option for scar amelioration. These strips, composed of 3mm medical-grade silicone, are effective in addressing a spectrum of scarring concerns, encompassing hypertrophic, keloid, post-surgical scars, and stretch marks. The underlying silicone technology functions by enclosing the scar area, fostering a moist environment conducive to optimal healing and consequently yielding substantial improvements in scar characteristics such as texture, pigmentation, and elevation. Engineered for wearability and subtlety, this product offers a convenient method for scar management within the home setting.
Hypertrophic And Keloid Scar Treatment Market Industry Leaders And Market Competition
Major companies operating in the hypertrophic and keloid scar treatment market are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Biodermis, Mederma, Silagen
Access The Complete Hypertrophic And Keloid Scar Treatment Market Report:
Hypertrophic And Keloid Scar Treatment Market Leading Geography: Which Region Generates The Most Revenue?
North Americawas the largest region in the hypertrophic and keloid scar treatment market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model